This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Aug 14;126(7):800-2.

doi: 10.1161/CIRCULATIONAHA.112.125013. Epub 2012 Jul 18.

Cardiac fibrosis revisited by microRNA therapeutics

Thomas Thum, Johan M Lorenzen

PMID: 22811579
DOI: 10.1161/CIRCULATIONAHA.112.125013

Editorial

Cardiac fibrosis revisited by microRNA therapeutics

Thomas Thum et al. Circulation. 2012.

. 2012 Aug 14;126(7):800-2.

doi: 10.1161/CIRCULATIONAHA.112.125013. Epub 2012 Jul 18.

Authors

Thomas Thum, Johan M Lorenzen

PMID: 22811579
DOI: 10.1161/CIRCULATIONAHA.112.125013

No abstract available

PubMed Disclaimer

Comment on

MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.
Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, Yuan Y, Zhang Y, Wang Y, Lu Y, Yang B. Pan Z, et al. Circulation. 2012 Aug 14;126(7):840-50. doi: 10.1161/CIRCULATIONAHA.112.094524. Epub 2012 Jul 18. Circulation. 2012. PMID: 22811578

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information